By Michele Maatouk
Date: Monday 17 Jun 2024
(Sharecast News) - Hikma Pharmaceuticals said on Monday that it has agreed to buy parts of Xellia Pharmaceuticals, a Copenhagen-based specialty company focusing on providing anti-infective treatments and other critical care therapies, for up to $185m.
By Michele Maatouk
Date: Tuesday 11 Jun 2024
(Sharecast News) - Citi lifted its price target on Hikma Pharmaceuticals on Tuesday to 2,845p from 2,770p as it said IQVIA April data highlighted "healthy trends" for injectables and US Generics.
By Josh White
Date: Thursday 25 Apr 2024
(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.
Currency | UK Pounds |
Share Price | 1,965.00p |
Change Today | 7.00p |
% Change | 0.36 % |
52 Week High | 2,205.00 |
52 Week Low | 1,722.00 |
Volume | 18,833 |
Shares Issued | 221.89m |
Market Cap | £4,360.05m |
RiskGrade | 125 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 4 |
Buy | 2 |
Neutral | 4 |
Sell | 1 |
Strong Sell | 0 |
Total | 11 |
Latest | Previous | |
---|---|---|
Final | Interim | |
Ex-Div | 21-Mar-24 | 10-Aug-23 |
Paid | 03-May-24 | 15-Sep-23 |
Amount | 47.00¢ | 25.00¢ |
Time | Volume / Share Price |
10:49 | 1,000 @ 1,965.82p |
10:49 | 20 @ 1,965.00p |
10:46 | 118 @ 1,965.00p |
10:46 | 43 @ 1,965.00p |
10:46 | 137 @ 1,964.00p |
You are here: research